Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01686061 · ClinicalTrials.gov registry record
Blepharospasm Patient Survey for Patients With Blepharospasm
A clinical trial, sponsored by Merz Pharmaceuticals.
- Completed
- Registry status
- 124
- Enrollment target
NCT01686061: Completed study, sponsored by Merz Pharmaceuticals.
NCT01686061 is a clinical trial that has completed, run by Merz Pharmaceuticals. The registered enrollment target is 124 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01686061 has completed, sponsored by Merz Pharmaceuticals.
- COMPLETED
- Registry status
- 124 participants
- Enrollment target
Study Summary
The purpose of this survey is to collect detailed information on patients treated for blepharospasm with incobotulinumtoxinA, abobotulinumtoxinA and onabotulinumtoxinA, including how often they are treated with botulinum toxin, how long their treatment lasts, how satisfied they are with their treatment, and if there is any improvement in their symptoms with the treatment.
Primary Outcome
The following information for patients treated for blepharospasm with incobotulinumtoxinA, abobotulinumtoxinA, or onabotulinumtoxinA treatment is collected: (1) botulinum treatment information such as intervals for botulinum injections, physician's rationale for injection interval, overall experience with botulinum toxin injections (onset, maximum effect, decline of effect), current injection cycle experience (current satisfaction, satisfaction at maximum effect, and visual analog scale (VAS) of
Interventions
- OTHER No intervention- only one time survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2012-09 |
| Est. Completion | 2013-04 |
What the finished NCT01686061 record still lists
NCT01686061 is an observational study that tracks outcomes without assigning an intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No intervention- only one time survey is the first listed.
NCT01686061 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01686061 about?
NCT01686061 is a clinical study titled "Blepharospasm Patient Survey for Patients With Blepharospasm". The purpose of this survey is to collect detailed information on patients treated for blepharospasm with incobotulinumtoxinA, abobotulinumtoxinA and onabotulinumtoxinA, including how often they are treated with botulinum toxin, how long their treatment lasts, how satisfied they are with their treatm...
What is the current status of trial NCT01686061?
This trial is currently completed. The enrollment target is 124 participants. The study started on 2012-09. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01686061?
The interventions under investigation include: No intervention- only one time survey (OTHER).
Who is sponsoring clinical trial NCT01686061?
This trial is sponsored by Merz Pharmaceuticals, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523014 · 124 participants · Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- NCT02670707 · 124 participants · Phase 3
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- NCT02830724 · 124 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- NCT04748809 · 124 participants · NA
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia